Atreca Announces Participation in Two Upcoming Virtual Investor Conferences

    NEXT STORY
    Demonstrating Value in the Real World
    PREV STORY
    Pharmactive Adopts Saffron through ABC’s Adopt-an-Herb Program
    Subscribe to PM360
    Follow Us

    Experts on Call

    Get in touch with PM360 Experts On Call

    Ads

    You May Also Like

    Stemline Therapeutics Announces Three ELZONRIS™ (tagraxofusp; SL-401) Clinical Presentations, Including an Oral Presentation, at the EHA Congress

    NEW YORK, June 14, 2018 (GLOBE NEWSWIRE) -- Stemline Therapeutics, Inc. (Nasdaq:STML), a clinical-stage ...

    author_avatar
    NASDAQ Market News

    EMA accepts regulatory submission for avalglucosidase alfa, a potentially new standard of care enzyme replacement therapy for Pompe disease

    author_avatar
    NASDAQ Market News

    CareDx Leads in Innovation with AlloSeq Portfolio at ASHI 2020

    author_avatar
    NASDAQ Market News